| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 116.86B | 111.03B | 101.40B | 93.02B | 84.78B | 80.62B |
| Gross Profit | 78.96B | 73.35B | 67.59B | 61.80B | 56.39B | 54.33B |
| EBITDA | 14.15B | 14.01B | 13.09B | 10.65B | 9.54B | 8.60B |
| Net Income | 8.07B | 8.07B | 7.91B | 6.21B | 8.81B | 4.29B |
Balance Sheet | ||||||
| Total Assets | 81.48B | 99.05B | 93.40B | 85.34B | 90.67B | 92.72B |
| Cash, Cash Equivalents and Short-Term Investments | 22.12B | 38.12B | 36.30B | 32.03B | 37.44B | 39.59B |
| Total Debt | 3.50B | 5.00B | 7.00B | 9.00B | 16.06B | 26.99B |
| Total Liabilities | 19.39B | 24.81B | 24.76B | 22.57B | 31.57B | 39.76B |
| Stockholders Equity | 62.09B | 74.24B | 68.64B | 62.77B | 59.10B | 52.95B |
Cash Flow | ||||||
| Free Cash Flow | 6.99B | 7.04B | 8.73B | 4.12B | 11.04B | 2.63B |
| Operating Cash Flow | 11.37B | 11.21B | 12.22B | 7.33B | 13.60B | 5.82B |
| Investing Cash Flow | -4.69B | -4.57B | -3.22B | -3.23B | -2.94B | -3.44B |
| Financing Cash Flow | -19.54B | -4.83B | -4.73B | -9.51B | -12.81B | 20.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥328.94B | 22.28 | 9.66% | 0.55% | 14.33% | 36.83% | |
66 Neutral | ¥188.00B | 27.13 | ― | 1.65% | 9.59% | 8.08% | |
63 Neutral | ¥774.42B | 45.71 | 9.53% | 0.55% | 15.58% | 60.90% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥1.49T | 28.68 | 15.36% | 0.78% | 11.29% | -4.88% | |
59 Neutral | ¥207.15B | 19.69 | ― | 0.29% | 8.99% | 61.95% | |
53 Neutral | ¥222.07B | 72.52 | ― | 0.69% | 10.75% | -14.28% |